Zobrazeno 1 - 10
of 315
pro vyhledávání: '"Renfurm, R."'
Autor:
Heerspink HJL; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.)., Jardine M; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.)., Kohan DE; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.)., Lafayette RA; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.)., Levin A; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.)., Liew A; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.)., Zhang H; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.)., Lodha A; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.)., Gray T; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.)., Wang Y; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.)., Renfurm R; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.)., Barratt J; From the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (M.J.); the Division of Nephrology, University of Utah Health, Salt Lake City (D.E.K.); Stanford University, Stanford, CA (R.A.L.); the University of British Columbia, Vancouver, Canada (A. Levin); Mount Elizabeth Novena Hospital, Singapore (A. Liew); Peking University First Hospital, Beijing (H.Z.); Chinook Therapeutics, Seattle (T.G.); Novartis, East Hanover, NJ (A. Lodha, Y.W.); Novartis, Basel, Switzerland (R.R.); and the University of Leicester, Leicester, United Kingdom (J.B.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.
Autor:
Perkovic V; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Barratt J; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Rovin B; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Kashihara N; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Maes B; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Zhang H; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Trimarchi H; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Kollins D; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Papachristofi O; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Jacinto-Sanders S; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Merkel T; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Guerard N; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Renfurm R; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Hach T; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.)., Rizk DV; From the University of New South Wales, Sydney (V.P.); the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.); Ohio State University Wexner Medical Center, Columbus (B.R.); Kawasaki Medical School, Okayama, Japan (N.K.); AZ Delta, Roeselare, Belgium (B.M.); Peking University First Hospital, Beijing (H.Z.); Hospital Britanico, Buenos Aires (H.T.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); and the University of Alabama at Birmingham, Birmingham (D.V.R.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.
Autor:
Mazer CD; Department of Anesthesia, St. Michael's Hospital, Toronto, Ontario, Canada.; Department of Anesthesiology and Pain Medicine, Physiology and Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada., Siadati-Fini N; Anaesthesia Department, St. Michael's Hospital, Toronto, Ontario, Canada., Boehm J; Department of Cardiovascular Surgery, Technische Universität München, Munchen, Germany.; Insure (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany., Wirth F; Department of Cardiovascular Surgery, Technische Universität München, Munchen, Germany.; Insure (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany., Myjavec A; Department of Cardiac Surgery, University of Hradec Kralove, Hradec Kralove, Czech Republic., Brown CD; Department of Cardiac Surgery, New Brunswick Heart Centre, Saint John, New Brunswick, Canada., Koyner JL; Department of Medicine, Section of Nephrology, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA., Boening A; Department of Cardiovascular Surgery, Justus-Liebig-University, Giessen, Germany., Engelman DT; Heart and Vascular Program, Baystate Medical Center, Springfield, Massachusetts, USA., Larsson TE; Guard Therapeutics, Stockholm, Sweden., Renfurm R; Global Drug Development Unit Cardio-Renal-Metabolism, Novartis Pharma AG, Basel, Switzerland., de Varennes B; Division of Cardiac Surgery, McGill University Faculty of Medicine, Montreal, Québec, Canada., Noiseux N; Division of Cardiac Surgery, Universite de Montreal, Montreal, Québec, Canada., Thielmann M; Department for Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany., Lamy A; Department for Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada., Laflamme M; Institut universitaire de cardiologie et de pneumologie de Québec, University of Quebec, Quebec, Quebec, Canada., von Groote T; Department of Anesthesiology, Intensive Care Medicine, University Hospital Münster, Munster, Germany., Ronco C; International Renal Research Institute of Vicenza, San Bortolo Hospital of Vicenza, Vicenza, Italy., Zarbock A; Department of Anesthesiology, Intensive Care Medicine, University Hospital Münster, Munster, Germany zarbock@uni-muenster.de.
Publikováno v:
BMJ open [BMJ Open] 2023 Apr 06; Vol. 13 (4), pp. e068363. Date of Electronic Publication: 2023 Apr 06.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ibrahim, Sabrin R. M.1 sabrin.ibrahim@bmc.edu.sa, Alzain, Abdulrahim A.2, Elbadwi, Fatima A.2, Koshak, Abdulrahman E.3, AlSaedi, Aram Hamad4, Ashour, Ahmed5, Osman, Wadah5, Sindi, Ikhlas A.6, El-Sayed, Selwan M.7, Farahat, Abdelbasset A.8, Hassan, Ahmed H. E.7, Mohamed, Gamal A.3
Publikováno v:
Journal of Applied Pharmaceutical Science. Oct2024, Vol. 14 Issue 10, p35-52. 18p.
Autor:
Stielow, J.B., Levesque, C.A., Seifert, K.A., Meyer, W., Irinyi, L., Smits, D., Renfurm, R., Verkley, G.J.M., Groenewald, M., Chaduli, D., Lomascolo, A., Welti, S., Lesage-Meessen, L., Favel, A., Al-Hatmi, A.M.S., Damm, U., Yilmaz, N., Houbraken, J., Lombard, L., Quaedvlieg, W., Binder, M., Vaas, L.A.I., Vu, D., Yurkov, A., Begerow, D., Roehl, O., Guerreiro, M., Fonseca, A., Samerpitak, K., Diepeningen, A.D. van, Dolatabadi, S., Moreno, L.F., Casaregola, S., Mallet, S., Jacques, N., Roscini, L., Egidi, E., Bizet, C., Garcia-Hermoso, D., Martin, M.P., Deng, S., Groenewald, J.Z., Boekhout, T., Beer, Z.W. de, Barnes, I., Duong, T.A., Wingfield, M.J., Hoog, G.S. de, Crous, P.W., Lewis, C.T., Hambleton, S., Moussa, T.A.A., Al-Zahrani, H.S., Almaghrabi, O.A., Louis-Seize, G., Assabgui, R., McCormick, W., Omer, G., Dukik, K., Cardinali, G., Eberhardt, U., Vries, M. de, Robert, V.
The aim of this study was to assess potential candidate gene regions and corresponding universal primer pairs as secondary DNA barcodes for the fungal kingdom, additional to ITS rDNA as primary barcode. Amplification efficiencies of 14 (partially) un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::5121036f2c17a6ea36af08bef19f5f70
https://publica.fraunhofer.de/handle/publica/243369
https://publica.fraunhofer.de/handle/publica/243369
Publikováno v:
Persoonia. National Herbarium Nederland
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::031e6fd92d0ac37bf3488efbb915b1e5
https://pure.knaw.nl/portal/en/publications/441b1368-e1f7-4c3c-8654-a056695518a0
https://pure.knaw.nl/portal/en/publications/441b1368-e1f7-4c3c-8654-a056695518a0
Autor:
Stielow, J. B., Lévesque, C. A., Seifert, K. A., Meyer, W., Irinyi, L., Smits, D., Renfurm, R., Verkley, G. J. M., Groenewald, M., Chaduli, D., Lomascolo, A., Welti, S., Lesage-Meessen, L., Favel, A., Al-Hatmi, A. M. S., Damm, U., Yilmaz, N., Houbraken, J., Lombard, L., Quaedvlieg, W.
Publikováno v:
Persoonia; Dec2015, Vol. 35, p242-263, 22p
Autor:
Lau, Meng Fei1,2 (AUTHOR), Phan, Chia Wei2,3 (AUTHOR), Sabaratnam, Vikineswary2,4 (AUTHOR), Kuppusamy, Umah Rani1,2 (AUTHOR) umah@um.edu.my
Publikováno v:
Mycology: An International Journal on Fungal Biology. Sep2024, Vol. 15 Issue 3, p360-373. 14p.
Autor:
Liu, Yinglong1 (AUTHOR) ynfh2007@163.com, Ahmed, Ayesha1 (AUTHOR), Munir, Shahzad1 (AUTHOR), Chen, Lei1 (AUTHOR), He, Pengfei1 (AUTHOR), He, Yueqiu1 (AUTHOR), Tang, Ping1 (AUTHOR), Kong, Baohua2 (AUTHOR), Wu, Yixin1 (AUTHOR) wyx680705@163.com, He, Pengbo1 (AUTHOR) wyx680705@163.com
Publikováno v:
Journal of Fungi. Jul2024, Vol. 10 Issue 7, p494. 12p.